Genotoxic effects of rotenone on cultured lymphocytes

Patrícia Danielle Lima de Lima1, Elizabeth Sumi Yamada, Edmar Tavares da Costa

  • 1Laboratório de Citogenética Humana, Departamento de Biologia, Centro de Ciências Biológicas, Hospital Universitário João de Barros Barreto, Universidade do Pará, Belém, PA, Brasil.

Insights

Rotenone, a pesticide, causes DNA damage and chromosome aberrations in human cells. Its genotoxic effects vary depending on the cell cycle phase, with clastogenicity observed during G1/S and S phases.

Area of Science:

  • Toxicology
  • Cell Biology
  • Genetics

Background:

  • Rotenone is a widely used insecticide, acaricide, and piscicide.
  • Its toxicity stems from inhibiting mitochondrial respiration, reducing ATP production, and generating reactive oxygen species (ROS).
  • ROS can damage DNA, RNA, and proteins, leading to cellular damage and death.

Purpose of the Study:

  • To evaluate the genotoxic and clastogenic effects of rotenone on human lymphocytes.
  • To assess these effects across different phases of the cell cycle (G1, G1/S, S, and G2).

Main Methods:

  • Utilized the Comet assay to detect DNA damage.
  • Analyzed chromosome aberrations to assess clastogenic effects.
  • Treated cultured human lymphocytes with varying concentrations of rotenone (1.0, 1.5, 2.0 microg/mL) during specific cell cycle phases.

Main Results:

  • Rotenone induced DNA damage and exhibited clastogenic effects, particularly when applied during the G1/S and S phases.
  • Treatments during the G1 phase led to endoreduplication and polyploidy.
  • A significant reduction in the mitotic index was observed across all treated cell cycle phases.

Conclusions:

  • Rotenone demonstrates genotoxic and clastogenic potential in human lymphocytes.
  • The observed effects are cell cycle-dependent, with distinct impacts on DNA integrity and chromosomal structure.
  • Rotenone's mechanism involves inducing DNA damage, aberrations, and alterations in cell cycle progression, contributing to its toxicity.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...